Download Folie 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
1ST ESDO - BGDO MASTERCLASS: INNOVATION IN GI CANCERS OCT 6 - 7, 2017
IRISH COLLEGE LEUVEN, BELGIUM
ONLINE REGISTRATION IS OPEN http://bit.ly/participant_MC2017
During two days, renowned European experts teach on the latest multidisciplinary innovations in Gastrointestinal
Cancer at the 1st ESDO-BGDO MASTERCLASS organized in collaboration between the European Society of Digestive
Oncology and the Belgian Group of Digestive Oncology. Details: www.esdo.eu/education/esdo-master-class
Scientific Committee:
Eric Van Cutsem
ESDO President / Belgium
Ivan Borbath
BGDO President / Belgium
Thomas Seufferlein
ESDO Secretary General / Germany
Jean-Luc Van Laethem ESDO Education Chair / Belgium
Faculty includes:
Pierre Coulie, Belgium / Christophe De Roose, Belgium / Ulrich Güller, Switzerland / Pierre Laurent-Puig, France /
Côme Lepage, France / Murielle Mauer (EORTC), Belgium / Markus Möhler, Germany / Wolff Schmiegel, Germany /
Max Seidensticker, Germany / Sabine Tejpar, Belgium / Aziz Zaanan, France
Interested physicians are welcome to submit a CV to ESDO office [email protected] Limited capacity for 60 persons
Applications considered on a first-come first-serve basis. ESDO provides accommodation and boarding and covers
international travel expenses up to € 250. Registration fee: 75 € ESDO & BGDO members (105 € non-members)
PROGRAMME
FRIDAY October 6, 2017

Advances in Immuno-Oncology in GI Cancer
•
Understanding immune mechanisms in cancer
and how to interfere?
Clinical trials in GI cancer
Design and interpretation of trials: hurdles,
requirements and condition (round table)
•
•

Technology Platforms for Molecular Drugs: how
to apply this in clinical practise
•
•
•
Clinical relevance of NGS
Liquid biopsies
Determining resistance and response to new
drugs
SATURDAY October 7, 2017

Statistics for the Clinicians

Functional imaging in GI cancer
•
•
General principles
Innovative design of trials in the era of targeted
agents

Clinical Relevance of Molecular Taxonomy
in GI Cancer
•
•
•
•
•
Functional imaging: the role of Ultrasonography
Functional MRI
PET/CT and PET/MRI
MRI in rectal cancer
Response evaluation after loco-regional therapy
•
•
•
Unraveling CRC
Pancreatic cancer
Gastric cancer
Organization:
Liz Tanzer [email protected] ww.esdo.eu
tel. +43 676 7076079
Onsite Organization: Anne-Sophie Wirtz www.bgdo.org
[email protected] tel. + 32 476 312 411